Goldman Sachs Group Inc Amyris, Inc. Call Options Transaction History

Goldman Sachs Group Inc

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 14, 2024	SELL	$1.09 - $1.82 $2.81 Million - $4.69 Million	-2,577,000 Reduced 95.39%	124,600 $169,000
Q1 2023 May 11, 2023	SELL	$1.09 - $1.82 $2.81 Million - $4.69 Million	-2,577,000 Reduced 95.39%	124,600 $169,000
Q4 2022 May 14, 2024	BUY	$1.52 - $3.39 $400,672 - $893,604	263,600 Added 10.81%	2,701,600 $4.13 Million
Q4 2022 Feb 13, 2023	BUY	$1.52 - $3.39 $400,672 - $893,604	263,600 Added 10.81%	2,701,600 $4.13 Million
Q2 2022 May 14, 2024	BUY	$1.6 - $5.07 $3.9 Million - $12.4 Million	2,438,000 New	2,438,000 $4.51 Million
Q1 2022 May 16, 2022	BUY	$3.92 - $5.86 $9.56 Million - $14.3 Million	2,438,000 New	2,438,000 $10.6 Million

230K

Ticker AMRS
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 324,860,000
Market Cap $3.25M
Description
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.